Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
2008 2
2009 4
2010 3
2011 1
2012 4
2013 2
2014 1
2015 2
2017 1
2018 2
2019 1
2020 4
2021 2
2022 4
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
Comorbidities in childhood atopic dermatitis: A population-based study.
von Kobyletzki L, Henrohn D, Ballardini N, Neary MP, Ortsäter G, Rieem Dun A, Geale K, Lindberg I, Theodosiou G, Neregård P, De Geer A, Cha A, Cappelleri JC, Thyssen JP. von Kobyletzki L, et al. Among authors: henrohn d. J Eur Acad Dermatol Venereol. 2024 Feb;38(2):354-364. doi: 10.1111/jdv.19569. Epub 2023 Oct 22. J Eur Acad Dermatol Venereol. 2024. PMID: 37824103
Care pathways in atopic dermatitis: a retrospective population-based cohort study.
von Kobyletzki L, Ballardini N, Henrohn D, Neary MP, Ortsäter G, Geale K, Rieem Dun A, Lindberg I, De Geer A, Neregård P, Cha A, Cappelleri JC, Romero W, Thyssen JP. von Kobyletzki L, et al. Among authors: henrohn d. J Eur Acad Dermatol Venereol. 2022 Sep;36(9):1456-1466. doi: 10.1111/jdv.18185. Epub 2022 May 18. J Eur Acad Dermatol Venereol. 2022. PMID: 35470924 Free PMC article.
Validation of Patient Identification Algorithms for Atopic Dermatitis Using Healthcare Databases.
Ortsäter G, De Geer A, Geale K, Rieem Dun A, Lindberg I, Thyssen JP, von Kobyletzki L, Ballardini N, Henrohn D, Neregård P, Cha A, Cappelleri JC, Neary MP. Ortsäter G, et al. Among authors: henrohn d. Dermatol Ther (Heidelb). 2022 Feb;12(2):545-559. doi: 10.1007/s13555-021-00670-1. Epub 2022 Jan 18. Dermatol Ther (Heidelb). 2022. PMID: 35041157 Free PMC article.
Age-based (<65 vs ≥65 years) incidence of infections and serious infections with tofacitinib versus biological DMARDs in rheumatoid arthritis clinical trials and the US Corrona RA registry.
Winthrop KL, Citera G, Gold D, Henrohn D, Connell CA, Shapiro AB, Shi H, Onofrei AM, Pappas DA, Schulze-Koops H. Winthrop KL, et al. Among authors: henrohn d. Ann Rheum Dis. 2021 Jan;80(1):134-136. doi: 10.1136/annrheumdis-2020-218992. Epub 2020 Oct 12. Ann Rheum Dis. 2021. PMID: 33046447 Free PMC article. No abstract available.
Influenza Adverse Events in Patients with Rheumatoid Arthritis, Ulcerative Colitis, or Psoriatic Arthritis in the Tofacitinib Clinical Development Programs.
Winthrop KL, Yndestad A, Henrohn D, Danese S, Marsal S, Galindo M, Woolcott JC, Jo H, Kwok K, Shapiro AB, Jones TV, Diehl A, Su C, Panés J, Cohen SB. Winthrop KL, et al. Among authors: henrohn d. Rheumatol Ther. 2023 Apr;10(2):357-373. doi: 10.1007/s40744-022-00507-z. Epub 2022 Dec 17. Rheumatol Ther. 2023. PMID: 36526796 Free PMC article.
31 results